Lyme Disease

New England Journal of Medicine

Volumn 321, Issue 9, 1989, Pages 586-596

  Steere, Allen C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; CHLORAMPHENICOL; DOXYCYCLINE; ERYTHROMYCIN; PENICILLIN G; TETRACYCLINE;

ARTHRITIS; ATRIOVENTRICULAR BLOCK; BORRELIA BURGDORFERI; DERMATITIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYME DISEASE; NEUROLOGICAL COMPLICATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW;

EID: 0024362494     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198908313210906     Document Type: Review

References (162)

1. Steere achéal, Malawista SE, Snydman DR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977; 20: 7–17.
2. Steere achéal, Malawista SE, Hardin JA, Ruddy S, Askenase W, Andiman WA. Erythema chronicum migrans and Lyme arthritis: the enlarging clinical spectrum. Ann Intern Med 1977; 86: 685–98.
3. Steere achéal, Broderick TF, Malawista SE. Erythema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick vector. Am J Epidemiol 1978; 108: 312–21.
4. Wallis RC, Brown SE, Kloter KO, Main AJ Jr. Erythema chronicum migrans and Lyme arthritis: field study of ticks. Am J Epidemiol 1978; 108: 322–7.
5. Steere achéal, Malawista SE. Cases of Lyme disease in the United States: locations correlated with distribution of Ixodes dammini. Ann Intern Med 1979; 91: 730–3.
6. Steere achéal, Malawista SE, Newman JH, Spieler PN, Bartenhagen NH. Antibiotic therapy in Lyme disease. Ann Intern Med 1980; 93: 1–8.
7. Afzelius A. Erythema chronicum migrans. Acta Derm Venereol (Stockh) 1921; 2: 120–5.
8. Lipschütz B. Weiterer Beitrag zur Kenntnis des “Erythema chronicum migrans.” Arch Dermatol Syph 1923; 143: 365–74.
9. Herxheimer K, Hartmann K. Ueber Acrodermatitis chronica atrophicans. Arch Dermatol Syph 1902; 61: 57–76, 255–300.
10. Bannwarth A. Zur Klinik und Pathogenese der “chronischen lymphocytaren Meningitis.” Arch Psychiatr Nervenkr 1944; 117: 161–85.
11. Lennhoff C. Spirochaetes in aetiologically obscure diseases. Acta Derm Venereol (Stockh) 1948; 28: 295–324.
12. Hollström E. Successful treatment of erythema migrans Afzelius. Acta Derm Venereol (Stockh) 1951; 31: 235–43.
13. Johnson RC, Schmid GP, Hyde FW, Steigerwalt AG, Brenner DJ. Borrelia burgdorferi sp. nov.: etiologic agent of Lyme disease. Int J Sys Bacteriol 1984; 34: 496–7.
14. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease — a tick-borne spirochetosis? Science 1982; 216: 1317–9.
15. Steere achéal, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med 1983; 308: 733–40.
16. Benach JL, Bosler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med 1983; 308: 7402.
17. Ackerman R, Kabatzki J, Boisten HP, et al. Spirochäten-Ätiologie der Erythema-chronicum-migrans-Krankheit. Dtsch Med Wochenschr 1984; 109: 92–7.
18. Preac-Mursic V, Wilske B, Schierz G, Pfister HW, Einhaupl K. Repeated isolation of spirochetes from the cerebrospinal fluid of a patient with meningoradiculitis Bannwarth. Eur J Clin Microbiol 1984; 3: 564–5.
19. Asbrink E, Hovmark A. Successful cultivation of spirochetes from skin lesions of patients with erythema chronica migrans afzelius and acrodermatitis chronica atrophicans. Acta Pathol Microbiol Immunol Scand 1985; 93: 161–3.
20. Barbour AG, Hayes SF. Biology of Borrelia species. Microbiol Rev 1986; 50: 381–400.
21. Barbour AG, Tessier SL, Todd WJ. Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect Immun 1983; 41: 795–804.
22. Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 1984; 57: 521–5.
23. Kurtti TJ, Munderloh UG, Johnson RC, Ahlstrand GG. Colony formation and morphology in Borrelia burgdorferi. J Clin Microbiol 1987; 25: 2054–8.
24. Schwan TG, Burgdorfer W, Garon CF. Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation. Infect Immun 1988; 56: 1831–6.
25. Hovind-Hougen K, Asbrink E, Stiernstedt G, Steere achéal, Hovmark A. Ultrastructural differences among spirochetes isolated from patients with Lyme disease and related disorders, and from Ixodes ricinus. Zentralbl Bakteriol Mikrobiol Hyg [A] 1986; 263: 103–11.
26. Hyde FW, Johnson RC. Genetic relationship of Lyme disease spirochetes to Borrelia, Treponema, and Leptospira spp. J Clin Microbiol 1984; 20: 151–4.
27. Barbour AG, Burgdorfer W, Grunwaldt E, Steere achéal. Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. J Clin Invest 1983; 72: 504–15.
28. Craft JE, Fischer DK, Shimamoto GT, Steere achéal. Antigens of Borrelia burgdorferi recognized during Lyme disease: appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. J Clin Invest 1986; 78: 934–9.
29. Benach JL, Coleman JL, Golightly MG. A murine IgM monoclonal antibody binds an antigenic determinant in outer surface protein A, an immunodominant basic protein of the Lyme disease spirochete. J Immunol 1988; 140: 265–72.
30. Barbour AG, Tessier SL, Hayes SF. Variation in a major surface protein of Lyme disease spirochetes. Infect Immun 1984; 45: 94–100.
31. Coleman JL, Benach JL. Isolation of antigenic components from the Lyme disease spirochete: their role in early diagnosis. J Infect Dis 1987; 155: 756–65.
32. Barbour AG, Hayes SF, Heiland RA, Schrumpf ME, Tessier SL. A Borrelia-specific monoclonal antibody binds to a flagellar epitope. Infect Immun 1986; 52: 549–54.
33. Hansen K, Bangsborg JM, Fjordvang H, Pedersen NS, Hindersson P. Immunochemical characterization of and isolation of the gene for a Borrelia burgdorferi immunodominant 60-kilodalton antigen common to a wide range of bacteria. Infect Immun 1988; 56: 2047–53.
34. Beck G, Habicht GS, Benach JL, Coleman JL. Chemical and biologic characterization of a lipopolysaccharide extracted from the Lyme disease spirochete (Borrelia burgdorferi). J Infect Dis 1985; 152: 108–17.
35. Takayama K, Rothenberg RJ, Barbour AG. Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun 1987; 55: 2311–3.
36. Barbour AG. Plasmid analysis of Borrelia burgdorferi, the Lyme disease agent. J Clin Microbiol 1988; 26: 475–8.
37. Barbour AG, Garon CF. Linear plasmids of the bacterium Borrelia burgdorferi have covalently closed ends. Science 1987; 237: 409–11.
38. Howe TR, Mayer LW, Barbour AG. A single recombinant plasmid expressing two major outer surface proteins of the Lyme disease spirochete. Science 1985; 227: 645–6.
39. Howe TR, LaQuier FW, Barbour AG. Organization of genes encoding two outer membrane proteins of the Lyme disease agent Borrelia burgdorferi within a single transcriptional unit. Infect Immun 1986; 54: 207–12.
40. Wilske B, Preac-Mursic V, Schierz G, Kuhbeck R, Barbour AG, Kramer M. Antigenic variability of Borrelia burgdorferi. Ann NY Acad Sci 1988; 539: 126–43.
41. Hyde FW, Johnson RC. Characterization of a circular plasmid from Borrelia burgdorferi, etiologic agent of Lyme disease. J Clin Microbiol 1988; 26: 2203–5.
42. Barbour AG, Heiland RA, Howe TR. Heterogeneity of major proteins in Lyme disease borreliae: a molecular analysis of North American and European isolates. J Infect Dis 1985; 152: 478–84.
43. LeFebvre RB, Perng GC, Johnson RC. Characterization of Borrelia burgdorferi isolates by restriction endonuclease analysis and DNA hybridization. J Clin Microbiol 1989; 27: 636–9.
44. Johnson RC, Kodner C, Russell M, Duray PH. Experimental infection of the hamster with Borrelia burgdorferi. Ann NY Acad Sci 1988; 539: 258–63.
45. Levine JF, Wilson ML, Spielman A. Mice as reservoirs of the Lyme disease spirochete. Am J Trop Med Hyg 1985; 34: 355–60.
46. Burgdorfer W, Lane RS, Barbour AG, Gresbrink RA, Anderson JR. The western black-legged tick, Ixodes pacificus: a vector of Borrelia burgdorferi. Am J Trop Med Hyg 1985; 34: 925–30.
47. Krampitz HE. In vivo isolation and maintenance of some wild strains of European hard tick spirochetes in mammalian and arthropod hosts: a parasitologist's view. Zentralbl Bakteriol Mikrobiol Hyg [A] 1986; 263: 21–8.
48. Dekonenko EJ, Steere achéal, Berardi VP, Kravchuk LN. Lyme borreliosis in the Soviet Union: a cooperative US-USSR report. J Infect Dis 1988; 158: 748–53.
49. Schulze TL, Bowen GS, Bosler EM, et al. Amblyomma americanum: a potential vector of Lyme disease in New Jersey. Science 1984; 224: 601–3.
50. Magnarelli LA, Anderson JF. Ticks and biting insects infected with the etiologic agent of Lyme disease, Borrelia burgdorferi. J Clin Microbiol 1988; 26: 1482–6.
51. Wilson ML, Spielman A. Seasonal activity of immature Ixodes dammini (Acari: Ixodidae). J Med Entomol 1985; 22: 408–14.
52. Matuschka FR, Spielman A. The emergence of Lyme disease in a changing environment in North America and central Europe. Exp Appl Acarol 1986; 2: 337–53.
53. Ribeiro JM, Mather TN, Piesman J, Spielman A. Dissemination and salivary delivery of Lyme disease spirochetes in vector ticks (Acari:Ixodidae). J Med Entomol 1987; 24: 201–5.
54. Benach JL, Coleman JL, Skinner RA, Bosler EM. Adult Ixodes dammini on rabbits: a hypothesis for the development and transmission of Borrelia burgdorferi. J Infect Dis 1987; 155: 1300–6.
55. Piesman J, Mather TN, Sinsky RJ, Spielman A. Duration of tick attachment and Borrelia burgdorferi transmission. J Clin Microbiol 1987; 557–8.
56. Magnarelli LA, Anderson JF, Chappell WA. Antibodies to spirochetes in white-tailed deer and prevalence of infected ticks from foci of Lyme disease in Connecticut. J Wildl Dis 1984; 20: 21–6.
57. Bosler EM, Ormiston BG, Coleman JL, Hanrahan JP, Benach JL. Prevalence of the Lyme disease spirochete in populations of white-tailed deer and white-footed mice. Yale J Biol Med 1984; 57: 651–9.
58. Wilson ML, Adler GH, Spielman A. Correlation between abundance of deer and that of the deer tick, Ixodes dammini (Acari: Ixodidae). Ann Entomol Soc Am 1986; 172–6.
59. Wilson ML, Telford SR III, Piesman J, Spielman A. Reduced abundance of immature Ixodes dammini (Acari: Ixodidae) following elimination of deer. J Med Entomol 1988; 25: 224–8.
60. Magnarelli LA, Anderson JF, Burgdorfer W, Chappell WA. Parasitism by Ixodes dammini (Acari: Ixodidae) and antibodies to spirochetes in mammals at Lyme disease foci in Connecticut, USA. J Med Entomol 1984; 21: 52–7.
61. Magnarelli LA, Anderson JF, Apperson CS, Fish D, Johnson RC, Chappell WC. Spirochetes in ticks and antibodies to Borrelia burgdorferi in white-tailed deer from Connecticut, New York State, and North Carolina. J Wildl Dis 1986; 22: 178–88.
62. Anderson JF. Mammalian and avian reservoirs for Borrelia burgdorferi. Ann NY Acad Sci 1988; 539: 180–91.
63. Komblatt AN, Urband PH, Steere achéal. Arthritis caused by Borrelia burgdorferi in dogs. J Am Vet Med Assoc 1985; 186: 960–4.
64. Marcus LC, Patterson MM, Gilfillan RE, Urband PH. Antibodies to Borrelia burgdorferi in New England horses: serologic survey. Am J Vet Res 1985; 46: 2570–1.
65. Burgess EC. Borrelia burgdorferi infection in Wisconsin horses and cows. Ann NY Acad Sci 1988; 539: 235–43.
66. Lyme disease — Connecticut. MMWR 1988; 37: 1–3.
67. Tsai TS, Bailey RE, Moore PS. National surveillance of Lyme disease 1987–1988. Conn Med 1989; 53: 324–6.
68. Stanek G, Pletschette M, Flamm H, et al. European Lyme borreliosis. Ann NY Acad Sci 1988; 539: 274–82.
69. Ai CX, Wen YX, Zhang YG, et al. Clinical manifestations and epidemiological characteristics of Lyme disease in Hailin county, Heilongjiang Province, China. Ann NY Acad Sci 1988; 539: 302–13.
70. Kawabata M, Baba S, Iguchi K, Yamaguti N, Russell H. Lyme disease in Japan and its possible incriminated tick vector, Ixodes persulcatus. J Infect Dis 1987; 156: 854.
71. Stewart A, Glass J, Patel A, Watt G, Cripps A, Clancy R. Lyme arthritis in the Hunter Valley. Med J Aust 1982; 1: 139.
72. Steere achéal, Bartenhagen NH, Craft JE, et al. The early clinical manifestations of Lyme disease. Ann Intern Med 1983; 99: 76–82.
73. Steere achéal, Taylor E, Wilson ML, Levine JF, Spielman A. Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population. J Infect Dis 1986; 154: 295–300.
74. Lastavica CC, Wilson ML, Berardi VP, Spielman A, Deblinger RD. Rapid emergence of a focal epidemic of Lyme disease in coastal Massachusetts. N Engl J Med 1989; 320: 133–7.
75. Hanrahan JP, Benach JL, Coleman JL, et al. Incidence and cumulative frequency of endemic Lyme disease in a community. J Infect Dis 1984; 150: 489–96.
76. Lane RS, Lavoie PE. Lyme borreliosis in California: acarological, clinical, and epidemiological studies. Ann NY Acad Sci 1988; 539: 192–203.
77. Asbrink E, Hovmark A. Early and late cutaneous manifestations of lxodesborne borreliosis (erythema migrans borreliosis, Lyme borreliosis). Ann NY Acad Sci 1988; 539: 4–15.
78. Berger BW, Kaplan MH, Rothenberg IR, Barbour AG. Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans. J Am Acad Dermatol 1985; 13: 444–9.
79. Sigal LH, Steere achéal, Freeman DH, Dwyer JM. Proliferative responses of mononuclear cells in Lyme disease: reactivity to Borrelia burgdorferi antigens is greater in joint fluid than in blood. Arthritis Rheum 1986; 29: 761–9.
80. Shrestha M, Grodzicki RL, Steere achéal. Diagnosing early Lyme disease. Am J Med 1985; 78: 235–40.
81. Duray PH, Steere achéal. Clinical pathologic correlations of Lyme disease by stage. Ann NY Acad Sci 1988; 539: 65–79.
82. Barthold SW, Moody KD, Terwilliger GA, Duray PH, Jacoby RO, Steere achéal. Experimental Lyme arthritis in rats infected with Borrelia burgdorferi. J Infect Dis 1988; 157: 842–6.
83. Moffat CM, Sigal LH, Steere achéal, Freeman DH, Dwyer JM. Cellular immune findings in Lyme disease: correlation with serum IgM and disease activity. Am J Med 1984; 77: 625–32.
84. Golightly M, Thomas J, Volkman D, Dattwyler R. Modulation of natural killer cell activity by Borrelia burgdorferi. Ann NY Acad Sci 1988; 539: 103–11.
85. Steere achéal, Hardin JA, Ruddy S, Mummaw JG, Malawista SE. Lyme arthritis: correlation of serum and cryoglobulin IgM with activity, and serum IgG with remission. Arthritis Rheum 1979; 22: 471–83.
86. Hardin JA, Steere achéal, Malawista SE. Immune complexes and the evolution of Lyme arthritis: dissemination and localization of abnormal Clq binding activity. N Engl J Med 1979; 301: 1358–63.
87. Kujala GA, Steere achéal, Davis JS IV. IgM rheumatoid factor in Lyme disease: correlation with disease activity, total serum IgM, and IgM antibody to Borrelia burgdorferi. J Rheumatol 1987; 14: 772–6.
88. Mackworth-Young CG, Harris EN, Steere achéal, et al. Anticardiolipin antibodies in Lyme disease. Arthritis Rheum 1988; 31: 1052–6.
89. Hechemy KE, Harris HL, Duerr MJ, Benach JL, Reimer CB. Immunoglobulin G subclasses specific to Borrelia burgdorferi in patients with Lyme disease. Ann NY Acad Sci 1988; 539: 162–9.
90. Kochi SK, Johnson RC. Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway. Infect Immun 1988; 56: 314–21.
91. Benach JL, Fleit HB, Habicht GS, Coleman JL, Bosler EM, Lane BP. Interactions of phagocytes with the Lyme disease spirochete: role of the Fc receptor. J Infect Dis 1984; 150: 497–507.
92. Reik L, Steere achéal, Bartenhagen NH, Shope RE, Malawista SE. Neurologic abnormalities of Lyme disease. Medicine (Baltimore) 1979; 58: 281–94.
93. Pachner AR, Steere achéal. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology 1985; 35: 47–53.
94. Ackermann R, Horstrup P, Schmidt R. Tick-borne meningopolyneuritis (Garin-Bujadoux, Bannwarth). Yale J Biol Med 1984; 57: 485–90.
95. Stiernstedt G, Gustaffsson R, Karlsson M, Svenungsson B, Skoldenberg B. Clinical manifestations and diagnosis of neuroborreliosis. Ann NY Acad Sci 1988; 539: 46–55.
96. Pachner AR, Steere achéal, Sigal LH, Johnson CJ. Antigen-specific proliferation of CSF lymphocytes in Lyme disease. Neurology 1985; 35: 1642–4.
97. Wilske B, Schierz G, Preac-Mursic V, et al. Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome). J Infect Dis 1986; 153: 304–14.
98. Henriksson A, Link H, Cruz M, Stiernstedt G. Immunoglobulin abnormalities in cerebrospinal fluid and blood over the course of lymphocytic meningoradiculitis (Bannwarth's syndrome). Ann Neurol 1986; 20: 337–45.
99. Martin R, Ortlauf J, Sticht-Groh V, Bogdahn U, Goldmann SF, Mertens HG. Borrelia burgdorferi-specific and autoreactive T-cell lines from cerebrospinal fluid in Lyme radiculomyelitis. Ann Neurol 1988; 24: 509–16.
100. Garcia-Monco JC, Coleman JL, Benach JL. Antibodies to myelin basic protein in Lyme disease. J Infect Dis 1988; 158: 667–8.
101. Clark JR, Carlson RD, Sasaki CT, Pachner AR, Steere achéal. Facial paralysis in Lyme disease. Laryngoscope 1985; 95: 1341–5.
102. Vallat JM, Hugon J, Lubeau M, Leboutet MJ, Dumas M, Desproges-Gotteron R. Tick-bite meningoradiculoneuritis: clinical, electrophysiologic, and histologic findings in 10 cases. Neurology 1987; 37: 749–53.
103. Sigal LH, Tatum AH. Lyme disease patients' serum contains IgM antibodies to Borrelia burgdorferi that cross-react with neuronal antigens. Neurology 1988; 38: 1439–42.
104. Steere achéal, Batsford WP, Weinberg M, et al. Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med 1980; 93: 8–16.
105. Marcus LC, Steere achéal, Duray PH, Anderson AE, Mahoney EB. Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis: demonstration of spirochetes in the myocardium. Ann Intern Med 1985; 103: 374–6.
106. McAlister HF, Klementowicz PT, Andrews C, Fisher JD, Feld M, Furman S. Lyme carditis: an important cause of reversible heart block. Ann Intern Med 1989; 110: 339–45.
107. Kirsch M, Ruben FL, Steere achéal, Duray PH, Norden CW, Winkelstein A. Fatal adult respiratory distress syndrome in a patient with Lyme disease. JAMA 1988; 259: 2737–9.
108. Goellner MH, Agger WA, Burgess JH, Duray PH. Hepatitis due to recurrent Lyme disease. Ann Intern Med 1988; 108: 707–8.
109. Atlas E, Novak SN, Duray PH, Steere achéal. Lyme myositis: muscle invasion by Borrelia burgdorferi. Ann Intern Med 1988; 109: 245–6.
110. Jacobs JC, Stevens M, Duray PH. Lyme disease simulating septic arthritis. JAMA 1986; 256: 1138–9.
111. Kramer N, Rickert RR, Brodkin RH, Rosenstein ED. Septal panniculitis as a manifestation of Lyme disease. Am J Med 1986; 81: 149–52.
112. Steere achéal, Duray PH, Kauffmann DJH, Wormser GP. Unilateral blindness caused by infection with the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med 1985; 103: 382–4.
113. Bialasiewicz AA, Ruprecht KW, Naumann GO, Blenk H. Bilateral diffuse choroiditis and exudative retinal detachments with evidence of Lyme disease. Am J Ophthalmol 1988; 105: 419–20.
114. Steere achéal, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med 1987; 107: 725–31.
115. Lawson JP, Steere achéal. Lyme arthritis: radiologic findings. Radiology 1985; 154: 37–43.
116. Steere achéal, Gibofsky A, Patarroyo ME, Winchester RJ, Hardin JA, Malawista SE. Chronic Lyme arthritis: clinical and immunogenetic differentiation from rheumatoid arthritis. Ann Intern Med 1979; 90: 896–901.
117. Johnston YE, Duray PH, Steere achéal, et al. Lyme arthritis: spirochetes found in synovial microangiopathic lesions. Am J Pathol 1985; 118: 26–34.
118. Steere achéal, Duray PH, Butcher EC. Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis: comparison with rheumatoid synovium and tonsillar lymphoid tissue. Arthritis Rheum 1988; 31: 487–95.
119. Snydman DR, Schenkein DP, Berardi VP, Lastavica CC, Pariser KM. Borrelia burgdorferi in joint fluid in chronic Lyme arthritis. Ann Intern Med 1986; 104: 798–800.
120. Schmidli J, Hunziker T, Moesli P, Schaad UB. Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis. J Infect Dis 1988; 158: 905–6.
121. Herzer P, Wilske B, Preac-Mursic V, Schierz G, Schattenkirchner M, Zollner N. Lyme arthritis: clinical features, serological, and radiographic findings of cases in Germany. Klin Wochenschr 1986; 64: 206–15.
122. Habicht GS, Beck G, Benach JL, Coleman JL, Leichtling KD. Lyme disease spirochetes induce human and murine interleukin 1 production. J Immunol 1985; 134: 3147–54.
123. Steere achéal, Brinckerhoff CE, Miller DJ, Drinker H, Harris ED Jr, Malawista SE. Elevated levels of collagenase and prostaglandin E2 from synovium associated with erosion of cartilage and bone in a patient with chronic Lyme arthritis. Arthritis Rheum 1980; 23: 591–9.
124. Steere achéal, Feld J, Winchester R. Association of chronic Lyme arthritis with increased frequencies of DR4 and 3. Arthritis Rheum 1988; 31: S98. abstract.
125. Ackermann R, Rehse-Kupper B, Gollmer E, Schmidt R. Chronic neurologic manifestations of erythema migrans borreliosis. Ann NY Acad Sci 1988; 539: 16–23.
126. Pachner AR, Duray P, Steere achéal. Central nervous system manifestations of Lyme disease. Arch Neurol 1989; 46: 790–5.
127. Broderick JP, Sandok BA, Mertz LE. Focal encephalitis in a young woman 6 years after the onset of Lyme disease: tertiary Lyme disease? Mayo Clin Proc 1987: 62: 313–6.
128. Reik L Jr, Burgdorfer W, Donaldson JO. Neurologic abnormalities in Lyme disease without erythema chronicum migrans. Am J Med 1986; 81: 73–8.
129. Halperin JJ, Little BW, Coyle PK, Dattwyler RJ. Lyme disease: cause of a treatable peripheral neuropathy. Neurology 1987; 37: 1700–6.
130. Halperin JJ, Luft BJ, Anand AK, et al. Lyme neuroborreliosis: central nervous system manifestations. Neurology 1989; 39: 753–9.
131. Baum J, Barza M, Weinstein P, Groden J, Aswad M. Bilateral keratitis as a manifestation of Lyme disease. Am J Ophthalmol 1988; 105: 75–7.
132. Kornmehl EW, Lesser RL, Jaros P, Rocco E, Steere achéal. Bilateral keratitis in Lyme disease. Ophthalmol (in press).
133. Schlesinger PA, Duray PH, Burke BA, Steere achéal, Stillman MT. Maternalfetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med 1985; 103: 67–9.
134. Weber K, Bratzke HJ, Neubert U, Wilske B, Duray PH. Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy. Pediatr Infect Dis J 1988; 7: 286–9.
135. Markowitz LE, Steere achéal, Benach JL, Slade JD, Broome CV. Lyme disease during pregnancy. JAMA 1986; 255: 3394–6.
136. Williams CL, Benach JL, Curran AS, Spierling P, Medici F. Lyme disease during pregnancy: a cord blood serosurvey. Ann NY Acad Sci 1988; 539: 504–6.
137. Craft JE, Grodzicki RL, Steere achéal. The antibody response in Lyme disease: evaluation of diagnostic tests. J Infect Dis 1984; 149: 789–95.
138. Russell H, Sampson JS, Schmid GP, Wilkinson HW, Plikaytis B. Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease. J Infect Dis 1984; 149: 465–70.
139. Magnarelli LA, Meegan JM, Anderson JF, Chappell WA. Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease. J Clin Microbiol 1984; 20: 181–4.
140. Hedberg CW, Osterholm MT, MacDonald KL, White KE. An interlaboratory study of antibody to Borrelia burgdorferi. J Infect Dis 1987; 155: 1325–7.
141. Berardi VE, Weeks KE, Steere achéal. Serodiagnosis of early Lyme disease: analysis of IgM and IgG antibody responses by using an antibody-capture enzyme immunoassay. J Infect Dis 1988; 158: 754–60.
142. Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG. Seronegative Lyme disease: dissociation of the specific T- and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med 1988; 319: 1441–6.
143. Zoschke D, Kolstoe J, Skemp A. Positive lymphocyte proliferation to borrelia in Lyme disease — a cautionary note. Arthritis Rheum 1989; 32: S45. abstract.
144. Duffy J, Mertz LE, Wobig GH, Katzmann JA. Diagnosing Lyme disease: the contribution of serologic testing. Mayo Clin Proc 1988; 63: 1116–21.
145. Grodzicki RL, Steere achéal. Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease. J Infect Dis 1988; 157: 790–7.
146. Mandell H, Steere achéal, Reinhardt BN, et al. Lack of antibodies to Borrelia burgdorferi in patients with amyotrophic lateral sclerosis. N Engl J Med 1989; 320: 255–6.
147. Hansen K, Hindersson P, Pedersen NS. Measurement of antibodies to the Borrelia burgdorferi flagellum improves serodiagnosis in Lyme disease. J Clin Microbiol 1988; 26: 338–46.
148. Magnarelli LA, Anderson JF, Barbour AG. Enzyme-linked immunosorbent assays for Lyme disease: reactivity of subunits of Borrelia burgdorferi. J Infect Dis 1989; 159: 43–9.
149. Fahrer H, Linden S vd, Sauvain M-J, Gerber N. “Lyme borreliosis”: an epidemiologic study in a Swiss risk population. Arthritis Rheum 1987; 30: S350. abstract.
150. Steere achéal, Hutchinson GJ, Rahn DW, et al. Treatment of the early manifestations of Lyme disease. Ann Intern Med 1983; 99: 22–6.
151. Steere achéal, Pachner AR, Malawista SE. Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. Ann Intern Med 1983; 99: 767–72.
152. Steere achéal, Green J, Schoen RT, et al. Successful parenteral penicillin therapy of established Lyme arthritis. N Engl J Med 1985; 312: 869–74.
153. Johnson SE, Klein GC, Schmid GP, Feeley JC. Susceptibility of the Lyme disease spirochete to seven antimicrobial agents. Yale J Biol Med 1984; 57: 549–53.
154. Preac-Mursic V, Wilske B, Schierz G. European Borrelia burgdorferi isolated from humans and ticks: culture conditions and antibiotic sensitivities. Zentralbl Bakteriol Mikrobiol Hyg [A] 1986; 263: 112–8.
155. Johnson RC, Kodner C, Russell M. In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents. Antimicrob Agents Chemother 1987; 31: 164–7.
156. Neu HC. A perspective on therapy of Lyme infection. Ann NY Acad Sci 1988; 539: 314–6.
157. Weber K, Schierz G, Wilske B, et al. Reinfection with erythema migrans disease. Infection 1986; 14: 32–5.
158. Skoldenberg B, Stiernstedt G, Karlsson M, Wretlind B, Svenungsson B. Treatment of Lyme borreliosis with emphasis on neurological disease. Ann NY Acad Sci 1988; 539: 317–23.
159. Dattwyler RJ, Halperin JJ, Volkman DJ, Luft BJ. Treatment of late Lyme borreliosis — randomised comparison of ceftriaxone and penicillin. Lancet 1988; 1: 1191–4.
160. Diringer MN, Halperin JJ, Dattwyler RJ. Lyme meningoencephalitis: report of a severe, penicillin-resistant case. Arthritis Rheum 1987; 30: 705–8.
161. Liu NY, Dinerman H, Levin RE, et al. Randomized trial of doxycycline vs. amoxicillin/probenecid for the treatment of Lyme arthritis: treatment of non-responders with IV penicillin or ceftriaxone. Arthritis Rheum 1989; 32: S46. abstract.
162. Costello CM, Steere achéal, Pinkerton RE, Feder HM Jr. Prospective study of tick bites in an endemic area for Lyme disease. J Infect Dis 1989; 159: 136–9.